Skip Nav Destination
Issues
1 April 2017
-
Cover Image
Cover Image
To discover interactions between germline variants and somatic events in cancer, Carter and colleagues performed a genome-wide association study, evaluating genomic data from The Cancer Genome Atlas (TCGA) including more than 5,900 tumors and 22 cancer types. Association studies that compared tumor-specific SNPs identified loci that were significantly associated with specific tumor types, while association testing of SNPs in TCGA samples and the alteration status of 138 cancer driver genes identified 35 associations between 28 germline loci and 20 cancer driver genes. Analysis of mutational heterogeneity based on germline loci identified 20 candidate cancer driver genes, 15 of which had not previously been shown to be frequently mutated. In addition to providing a resource of germline–somatic interactions in cancer, these findings demonstrate that inherited risk variants can alter the somatic evolution of cancer. For details, please see the article by Carter and colleagues on page 410. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 2159-8274
EISSN 2159-8290
Issue Sections
In This Issue
In the Spotlight
Mini Review
Research Briefs
The Genetic Basis of Hepatosplenic T-cell Lymphoma
Matthew McKinney; Andrea B. Moffitt; Philippe Gaulard; Marion Travert; Laurence De Leval; Alina Nicolae; Mark Raffeld; Elaine S. Jaffe; Stefania Pittaluga; Liqiang Xi; Tayla Heavican; Javeed Iqbal; Karim Belhadj; Marie Helene Delfau-Larue; Virginie Fataccioli; Magdalena B. Czader; Izidore S. Lossos; Jennifer R. Chapman-Fredricks; Kristy L. Richards; Yuri Fedoriw; Sarah L. Ondrejka; Eric D. Hsi; Lawrence Low; Dennis Weisenburger; Wing C. Chan; Neha Mehta-Shah; Steven Horwitz; Leon Bernal-Mizrachi; Christopher R. Flowers; Anne W. Beaven; Mayur Parihar; Lucile Baseggio; Marie Parrens; Anne Moreau; Pierre Sujobert; Monika Pilichowska; Andrew M. Evens; Amy Chadburn; Rex K.H. Au-Yeung; Gopesh Srivastava; William W. L. Choi; John R. Goodlad; Igor Aurer; Sandra Basic-Kinda; Randy D. Gascoyne; Nicholas S. Davis; Guojie Li; Jenny Zhang; Deepthi Rajagopalan; Anupama Reddy; Cassandra Love; Shawn Levy; Yuan Zhuang; Jyotishka Datta; David B. Dunson; Sandeep S. Davé
Research Articles
Author Choice
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon; Salvatore Siena; Sai-Hong Ignatius Ou; Manish Patel; Myung Ju Ahn; Jeeyun Lee; Todd M. Bauer; Anna F. Farago; Jennifer J. Wheler; Stephen V. Liu; Robert Doebele; Laura Giannetta; Giulio Cerea; Giovanna Marrapese; Michele Schirru; Alessio Amatu; Katia Bencardino; Laura Palmeri; Andrea Sartore-Bianchi; Angelo Vanzulli; Sara Cresta; Silvia Damian; Matteo Duca; Elena Ardini; Gang Li; Jason Christiansen; Karey Kowalski; Ann D. Johnson; Rupal Patel; David Luo; Edna Chow-Maneval; Zachary Hornby; Pratik S. Multani; Alice T. Shaw; Filippo G. De Braud
Author Choice
Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer
Hannah Carter; Rachel Marty; Matan Hofree; Andrew M. Gross; James Jensen; Kathleen M. Fisch; Xingyu Wu; Christopher DeBoever; Eric L. Van Nostrand; Yan Song; Emily Wheeler; Jason F. Kreisberg; Scott M. Lippman; Gene W. Yeo; J. Silvio Gutkind; Trey Ideker
Author Choice
The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function
Lixin Wan; Ming Chen; Juxiang Cao; Xiangpeng Dai; Qing Yin; Jinfang Zhang; Su-Jung Song; Ying Lu; Jing Liu; Hiroyuki Inuzuka; Jesse M. Katon; Kelsey Berry; Jacqueline Fung; Christopher Ng; Pengda Liu; Min Sup Song; Lian Xue; Roderick T. Bronson; Marc W. Kirschner; Rutao Cui; Pier Paolo Pandolfi; Wenyi Wei
News in Brief
Research Watch
Clinical Trials
Drug Design
Epigenetics
Ewing Sarcoma
Genomics
Immunology
Metabolism
Metastasis
Pancreatic Cancer
Retinoblastoma
Structural Biology
Telomeres
Transcription
Tumor Heterogeneity
Tumor Suppressors
Tumorigenesis
Advertisement